AzTrials
AzTrials

Cancer PainNCT07916402

Home-Based Foot Reflexology for Pain in Patients With Advanced Cancer

A study testing Foot Reflexology in people with Cancer Pain and Advanced Cancer, run by Rawan AlAssaf at 1 site in Jordan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study examined changes in pain during a home-based foot reflexology program for adults with advanced cancer in Jordan. Foot reflexology involves applying pressure to selected areas of the feet. The main questions were: 1. How did pain scores change immediately after each foot reflexology session? 2. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cancer Pain, Advanced Cancer
What is being tested?
Foot Reflexology
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteJordan
Study dates
7 Feb 2025to 11 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older.
  • Diagnosis of advanced cancer, characterized using the tumor-node-metastasis (TNM) classification.
  • Moderate-to-severe cancer-related pain, defined as a Numerical Pain Rating Scale (NPRS) score of 4 or higher, reported to the pain clinic.

Who cannot join

  • Gout.
  • Leg ulcers.
  • Peripheral vascular disease.
  • Deep vein thrombosis.
  • Infections, wounds, or bruises that could interfere with foot reflexology.
  • Lymphedema that could interfere with foot reflexology.

Trial locations and contacts

1 site in 1 country.

Jordan1 site
  • Military Oncology Center, Queen Alia Military Hospital

    Amman, Amman Governorate, 11623

Other trials in Jordan

About this study

Official title: Changes in Pain Intensity During Home-Based Foot Reflexology in Patients With Advanced Cancer: A Prospective Study

This study examined changes in pain during a home-based foot reflexology program for adults with advanced cancer in Jordan. Foot reflexology involves applying pressure to selected areas of the feet.

The main questions were:

Read more
  1. How did pain scores change immediately after each foot reflexology session?
  2. How did pain scores change over the eight-week program?

Participants received up to 15 at-home sessions over eight weeks, usually twice a week. Each session included 30 minutes of foot reflexology delivered by a trained, certified practitioner. Participants rated their pain from 0 (no pain) to 10 (worst possible pain) immediately before each session and within five minutes after.

All participants continued their usual cancer treatment and pain care. Everyone received foot reflexology; there was no separate comparison group. Researchers compared each participant's pain scores before and after sessions and across the program.

Read the detailed description

This prospective, single-group, nonrandomized interventional study included repeated pain assessments. Adults with advanced cancer and moderate-to-severe cancer-related pain were recruited through the outpatient pain and oncology clinics of a military oncology center in Amman, Jordan. Researchers delivered the intervention in participants' homes. The study had no concurrent control group, random allocation, or masking.

The study examined two patterns of pain change: immediate within-session changes and longitudinal changes during the intervention period. We assessed immediate changes by comparing pain scores recorded before and after each session. We assessed longitudinal changes by examining pre-session pain scores across the program.

The intervention followed a standardized Sorensensistem foot reflexology protocol. A certified reflexology practitioner delivered up to 15 sessions over eight weeks, generally twice weekly. Each home visit lasted approximately 40 minutes, including preparation and pre-session assessment, 30 minutes of manual foot reflexology, and post-session assessment and rest. Participants were instructed to report discomfort, which would prompt termination of the session.

Pain intensity was measured using the 11-point Numerical Pain Rating Scale, ranging from 0 (no pain) to 10 (worst possible pain). Assessments were completed immediately before each session and within five minutes after. We also collected baseline demographic and clinical information.

Participants continued their prescribed oncology treatment and supportive care. We documented changes in prescribed analgesics and cancer treatments during the intervention period. We provided foot reflexology as an adjunct to usual care, not as a replacement for prescribed treatment.

Pain assessments were limited to the eight-week intervention period. We conducted no follow-up assessments after the program ended. Because the study did not include a control group, we cannot determine whether foot reflexology itself caused the observed changes in pain.

Being tested
Foot Reflexology
Keywords
Foot Reflexology, Pain Management, Home-Based Intervention, Nonpharmacological Intervention, Supportive Cancer Care, Numerical Pain Rating Scale
Medical subject headings
Cancer Pain, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Foot ReflexologyOther

    A certified practitioner delivered a standardized manual foot reflexology intervention following the Sorensensistem protocol in participants' homes. Treatment involved applying pressure to selected areas of the feet in a predefined sequence. Each treatment session lasted 30 minutes, and participants received up to 15 sessions over eight weeks, generally twice weekly. The intervention was provided alongside usual medical and oncology care.

Study groups in NCT07916402
Study groupRoleWhat they receive
Home-Based Foot ReflexologyExperimentalParticipants received up to 15 home-based foot reflexology sessions over eight weeks, generally twice weekly. Each session included 30 minutes of standardized foot reflexology delivered by a certified practitioner. Participants continued their usual oncology treatment and supportive care. Pain intensity was assessed immediately before and within five minutes after each session.
Receives: Other: Foot Reflexology

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Within-Session Change in Pain Intensity Measured by the Numerical Pain Rating Scale

    Pain intensity was measured using the 11-point Numerical Pain Rating Scale (NPRS), ranging from 0 (no pain) to 10 (worst possible pain). We recorded scores immediately before and within five minutes after each foot reflexology session. We calculated within-session change as the pre-session score minus the post-session score, with positive values indicating reduced pain. Changes were assessed across 15 sessions.

    Measured: Immediately before and within five minutes after each of 15 sessions over eight weeks.

Secondary outcomes (1)
  1. Change in Pre-Session Pain Intensity Across the Foot Reflexology Program

    We assessed pain intensity immediately before each session using the Numerical Pain Rating Scale (NPRS), ranging from 0 (no pain) to 10 (worst possible pain). We assessed pre-session scores across the 15-session program to describe changes over time. Lower scores indicate less pain.

    Measured: Immediately before each of the 15 sessions over eight weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2026
  2. Study start7 Feb 2025
  3. Primary completion11 Apr 2025
  4. Study completion11 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07916402
Sponsor's protocol ID
FR-PAIN-2025-01
Status last verified
Oct 2026
First submitted
30 Oct 2026
Last updated
4 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is currently no plan to share individual participant data with other researchers. Study findings will be reported in aggregate form in scientific publications.

Questions about this trial

What is this clinical trial studying?

A study testing Foot Reflexology in people with Cancer Pain and Advanced Cancer, run by Rawan AlAssaf at 1 site in Jordan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Within-Session Change in Pain Intensity Measured by the Numerical Pain Rating Scale (time frame: Immediately before and within five minutes after each of 15 sessions over eight weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in